Founder

Dr. Hector Zenil.

Founder and CEO of Algocyte, a healthcare intelligence company developing advanced infrastructure for predictive, personalised and precision-oriented healthcare.

Dr. Hector Zenil
Founder & CEO

Dr. Hector Zenil FRSM

Ph.D. in Computer Science (Lille) & Ph.D. in Epistemology (Paris, Sorbonne, ENS). Fellow of the Royal Society of Medicine. Associate Professor in Healthcare Engineering at King's College London.

hectorzenil.com

Dr. Hector Zenil is the Founder and CEO of Algocyte, a healthcare intelligence company developing advanced infrastructure for predictive, personalised and precision-oriented healthcare.

Algocyte combines physics-informed AI, causal AI, longitudinal modelling, blood testing, self-testing infrastructure, wearable integrations, and patient intelligence systems into one connected ecosystem designed for home-based healthcare management.

The company's vision is to help move healthcare from fragmented, reactive, institution-centred systems towards proactive, user-controlled, and longitudinal healthcare experiences accessible directly from home.

Its flagship device, Algocyte Proxima, is an ultra-portable, smartphone-controlled health testing platform designed to support regular health monitoring, patient engagement, and family healthcare management.

Dr. Zenil's work focuses on the intersection of AI, healthcare infrastructure, Physical AI systems, and causal reasoning for advanced patient intelligence applications.

The scientific and technical direction behind Algocyte is informed by work and collaboration connected to institutions including Oxford, Cambridge, and King's College London.

Get in touch

For research collaborations, partnership enquiries and speaking requests, email changetheworld@immunealgorithmics.com. You can also find more of Dr. Zenil's research, publications and talks at hectorzenil.com.

Bring regular immune monitoring to your patients.

Book a 20-minute briefing with our clinical team to see Algocyte in action.